Envoy Medical, Inc Warrant (COCHW) Stock Price

COCHWStock

$0.04

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta1.31

COCHW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-38.18%

Price vs S&P 500 (4W)-29.80%

VGM Score17.24

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
EWEdwards Lifesciences Corp	D	C	B	$90.87
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
ENOVEnovis Corporation	B	D	C	$25.58
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
MYOMyomo Inc.	C	B	B	$1.48
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About Envoy Medical, Inc Warrant

Envoy Medical Inc develops and commercializes fully implantable hearing aid systems, primarily the Esteem FI-AMEI implant. The company generates revenue through the sale of implants and replacement components to healthcare providers and patients seeking alternative hearing solutions. The Esteem FI-AMEI represents the company's core offering in the medical hearing device market.